Fundamental Analysis
37 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -24.8% | -21.3% | 0 / 3 | +29.2% | -2.16 pp | -0.28 pp | -6.5% | 0.75 | — | 159 | +29,2% | −25,4 | −31,4% | — | 10.66 | — |
| Pts | 0 | 0 | 0 | 12 | 4 | 4 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 7.240 (close price on 2026-10-19)EPS (TTM): −660,3
Financial charts
1.Revenue & growth
VND bn159Q2/26
1.Revenue & growth
VND bn159Q2/26
2.Profit & growth
VND bn-24,0Q2/26
3.Profit mix (Penman)
VND bn-109Q2/26
4.Margins & cost structure
%4.5%Q2/26
5.Returns & cash cycle
% · days-1.8%Q2/26
6.Earnings quality & cash
VND bn13,2Q2/26
7.Asset structure
VND bn3.024Q2/26
8.Funding & debt health
VND bn · times3.024Q2/26
9.Revenue backlog
VND bn2,22Q2/26
10.Valuation
times · %-12,5×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %-145Q2/26
Adjusted EPS growth, latest quarter
No comparable quarter a year earlier
Average adjusted EPS growth, 3 quarters
No comparable quarter a year earlier
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
-0.0%
Source: vnstockData through Q2/26